Wellington portfolio
Updated November 15, 2026
Wellington (Wellington Management) — One of the oldest independent investment firms, managing money for Vanguard's active funds and pension plans.
According to the latest 13F report that Wellington Management filed with the SEC (Q2 2026, filed August 14, 2026), its US stock portfolio is worth about $579.4B across 1823 holdings. The largest positions are Nvidia CorpNVDA, Broadcom IncAVGO, Microsoft CorpMSFT, and the top 10 make up 25% of the portfolio.
| # | Stock | Weight | Value | Change this quarter |
|---|---|---|---|---|
| 1 | Nvidia CorpNVDA | 4.2% | $24.4B | Trimmed +9% |
| 2 | Broadcom IncAVGO | 3.4% | $19.5B | Added +4% |
| 3 | Microsoft CorpMSFT | 3.1% | $17.8B | Trimmed +10% |
| 4 | Apple IncAAPL | 3.0% | $17.2B | Trimmed +9% |
| 5 | Alphabet Inc-cl AGOOGL | 2.7% | $15.9B | Trimmed +7% |
| 6 | ELI Lilly & CoLLY | 2.3% | $13.2B | Trimmed +18% |
| 7 | Amazon.com IncAMZN | 2.3% | $13.1B | Trimmed +12% |
| 8 | Merck & CO. Inc.MRK | 1.9% | $11.1B | Added +2% |
| 9 | Mastercard Inc - AMA | 1.1% | $6.5B | Trimmed +2% |
| 10 | Alphabet Inc-cl CGOOG | 1.1% | $6.1B | Added +25% |
| 11 | Micron Technology IncMU | 1.0% | $5.8B | Added +29% |
| 12 | Johnson & JohnsonJNJ | 1.0% | $5.7B | Added +13% |
| 13 | Advanced Micro DevicesAMD | 0.9% | $5.4B | Added +34% |
| 14 | Astrazeneca PLCAZN | 0.9% | $5.4B | Added +20% |
| 15 | KLA CorpKLAC | 0.8% | $4.5B | Added +929% |
| 16 | Unitedhealth Group IncUNH | 0.8% | $4.4B | Added +6% |
| 17 | Blackrock IncBLK | 0.7% | $4.3B | Added +23% |
| 18 | Tesla IncTSLA | 0.7% | $4.1B | Added +8% |
| 19 | Meta Platforms Inc-class AMETA | 0.7% | $4.1B | Trimmed +38% |
| 20 | SempraSRE | 0.7% | $4.1B | Trimmed +5% |
| 21 | Texas Instruments IncTXN | 0.7% | $3.9B | Trimmed +3% |
| 22 | Targa Resources CorpTRGP | 0.7% | $3.8B | Trimmed +6% |
| 23 | Elevance Health IncELV | 0.6% | $3.6B | Added +12% |
| 24 | Cardinal Health IncCAH | 0.6% | $3.5B | Added +248% |
| 25 | CVS Health CorpCVS | 0.6% | $3.5B | Added +50% |
| 26 | Welltower IncWELL | 0.6% | $3.4B | Trimmed +10% |
| 27 | Visa Inc-class A SharesV | 0.6% | $3.4B | Trimmed +4% |
| 28 | Corning IncGLW | 0.6% | $3.4B | Added +51% |
| 29 | Wells Fargo & CoWFC | 0.6% | $3.3B | Trimmed +40% |
| 30 | Philip Morris InternationalPM | 0.5% | $3.2B | Added +4% |
| 31 | Danaher CorpDHR | 0.5% | $3.1B | Added +10% |
| 32 | Walt Disney Co/theDIS | 0.5% | $3.1B | Added +15% |
| 33 | Taiwan Semiconductor-sp ADRTSM | 0.5% | $3.0B | Trimmed +16% |
| 34 | UBS Group AGUBS | 0.5% | $3.0B | Added +19% |
| 35 | Amphenol Corp-cl AAPH | 0.5% | $2.9B | Added +11% |
| 36 | Flex LTDFLEX | 0.5% | $2.9B | Trimmed +11% |
| 37 | Eaton Corp PLCETN | 0.5% | $2.9B | Added +20% |
| 38 | Diamondback Energy IncFANG | 0.5% | $2.9B | Added +31% |
| 39 | Marsh & Mclennan COSMRSH | 0.5% | $2.8B | Trimmed +2% |
| 40 | Dominion Energy IncD | 0.5% | $2.8B | Trimmed +14% |
Positions sold out
Honeywell Intl IncHON, Coterra Energy IncCTRA, Ascendis Pharma A/SASND, Avantor IncAVTR, Carnival CorpCCL, Shake Shack Inc - Class ASHAK, Soleno Therapeutics Inc, Invesco S&P 500 Equal WeightRSP, Regency Centers CorpREG, Booz Allen Hamilton HoldingsBAH, KBR IncKBR, Leonardo DRS IncDRS, Wesbanco IncWSBC, Abercrombie & Fitch Co-cl AANF, Flushing Finl Corp
Frequently asked questions
What does Wellington own now?
According to the latest 13F (Q2 2026), the largest holdings are Nvidia CorpNVDA, Broadcom IncAVGO, Microsoft CorpMSFT. The full list is in the table above.
What is a 13F report?
US investment managers with more than $100 million in US stocks must list their holdings with the SEC within 45 days after each quarter ends.
Why is the data delayed?
Because 13F reports arrive up to 45 days after the quarter ends, the manager may have traded since then.
Should I copy this portfolio?
Knowing what great investors buy is a good source of ideas, but because of the delay and different goals, copying blindly is not recommended.
More lists and tools
Lists are generated automatically from SEC filings and market prices and rebuilt every day. They are a starting point for research, not a recommendation to buy or sell.